Are Wall Street Analysts Bullish on Viatris Stock?

With a market cap of $18.1 billion, Viatris Inc. (VTRS) is a global healthcare company focused on providing branded medicines, generic drugs, biosimilars, and over-the-counter products across more than 165 countries. Headquartered in Pennsylvania, Viatris operates a broad portfolio spanning cardiovascular, infectious disease, immunology, oncology, dermatology, and central nervous system treatments. 

Shares of the company have outperformed the broader market over the past 52 weeks. VTRS stock has soared 80.7% over this time frame, while the broader S&P 500 Index ($SPX) has gained 28.5%. Moreover, the stock has returned 24.7% on a YTD basis, compared to SPX's 6% rise.